We are grateful for external funding from The Research Council of Norway, Norwegian Cancer Society, South-Eastern Norway Regional Health Authority and EU.
Tunheim G, Fossum E, Robertson AH, Rø GØI, Chopra A, Vaage JT, Vikse EL, Kran AB, Magnus P, Trogstad L, Mjaaland S, Hungnes O, Lund-Johansen F(2024) Characterization of the SARS-CoV-2 antibody landscape in Norway in the late summer of 2022: high seroprevalence in all age groups with patterns of primary Omicron infection in children and hybrid immunity in adults BMC Infect Dis, 24(1), 841 DOI 10.1186/s12879-024-09670-w, PubMed 39164637
Haghmorad D, Oksenych V, Huszthy PC(2024) Editorial: Exploring the role of T helper cells in autoimmune disease Front Immunol, 15, 1434684 DOI 10.3389/fimmu.2024.1434684, PubMed 38903522
Ng BD, Rajagopalan A, Kousa AI, Fischman JS, Chen S, Massa A, Elias HK, Manuele D, Galiano M, Lemarquis AL, Boardman AP, DeWolf S, Pierce J, Bogen B, James SE, van den Brink MRM(2024) IL-18-secreting multiantigen targeting CAR T cells eliminate antigen-low myeloma in an immunocompetent mouse model Blood, 144(2), 171-186 DOI 10.1182/blood.2023022293, PubMed 38579288